AU2016264102A1 - Compositions and methods for enriching populations of nucleic acids - Google Patents
Compositions and methods for enriching populations of nucleic acids Download PDFInfo
- Publication number
- AU2016264102A1 AU2016264102A1 AU2016264102A AU2016264102A AU2016264102A1 AU 2016264102 A1 AU2016264102 A1 AU 2016264102A1 AU 2016264102 A AU2016264102 A AU 2016264102A AU 2016264102 A AU2016264102 A AU 2016264102A AU 2016264102 A1 AU2016264102 A1 AU 2016264102A1
- Authority
- AU
- Australia
- Prior art keywords
- nucleic acids
- host
- oligonucleotides
- sample
- nucleotides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 1002
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 952
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 952
- 238000000034 method Methods 0.000 title claims abstract description 407
- 239000000203 mixture Substances 0.000 title claims abstract description 53
- 244000052769 pathogen Species 0.000 claims abstract description 94
- 230000001717 pathogenic effect Effects 0.000 claims abstract description 58
- 108091034117 Oligonucleotide Proteins 0.000 claims description 627
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 459
- 239000000523 sample Substances 0.000 claims description 357
- 125000003729 nucleotide group Chemical group 0.000 claims description 310
- 239000002773 nucleotide Substances 0.000 claims description 309
- 108020004414 DNA Proteins 0.000 claims description 187
- 241000282414 Homo sapiens Species 0.000 claims description 141
- 230000001580 bacterial effect Effects 0.000 claims description 117
- 230000003612 virological effect Effects 0.000 claims description 113
- 238000012163 sequencing technique Methods 0.000 claims description 85
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 71
- 210000001808 exosome Anatomy 0.000 claims description 70
- 230000000295 complement effect Effects 0.000 claims description 67
- 238000003556 assay Methods 0.000 claims description 62
- 108010033040 Histones Proteins 0.000 claims description 51
- 241000700605 Viruses Species 0.000 claims description 46
- 210000002381 plasma Anatomy 0.000 claims description 39
- 230000003115 biocidal effect Effects 0.000 claims description 38
- 238000006243 chemical reaction Methods 0.000 claims description 38
- 244000045947 parasite Species 0.000 claims description 36
- 241000894006 Bacteria Species 0.000 claims description 32
- 241000233866 Fungi Species 0.000 claims description 32
- 101710163270 Nuclease Proteins 0.000 claims description 32
- 230000000813 microbial effect Effects 0.000 claims description 32
- 239000000126 substance Substances 0.000 claims description 32
- 108010047956 Nucleosomes Proteins 0.000 claims description 27
- 210000001623 nucleosome Anatomy 0.000 claims description 27
- 239000007787 solid Substances 0.000 claims description 27
- 210000004369 blood Anatomy 0.000 claims description 26
- 239000008280 blood Substances 0.000 claims description 26
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 22
- 210000000265 leukocyte Anatomy 0.000 claims description 20
- 102000053602 DNA Human genes 0.000 claims description 19
- 230000000873 masking effect Effects 0.000 claims description 18
- 210000002966 serum Anatomy 0.000 claims description 18
- 230000003321 amplification Effects 0.000 claims description 17
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 17
- 230000003287 optical effect Effects 0.000 claims description 17
- 102000006947 Histones Human genes 0.000 claims description 16
- 102100033636 Histone H3.2 Human genes 0.000 claims description 15
- 230000037452 priming Effects 0.000 claims description 15
- 230000002538 fungal effect Effects 0.000 claims description 14
- 238000010379 pull-down assay Methods 0.000 claims description 14
- 230000000845 anti-microbial effect Effects 0.000 claims description 12
- 230000000840 anti-viral effect Effects 0.000 claims description 12
- 239000003096 antiparasitic agent Substances 0.000 claims description 12
- 229960002685 biotin Drugs 0.000 claims description 11
- 235000020958 biotin Nutrition 0.000 claims description 11
- 239000011616 biotin Substances 0.000 claims description 11
- 239000002299 complementary DNA Substances 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 11
- 238000006116 polymerization reaction Methods 0.000 claims description 11
- 102100031780 Endonuclease Human genes 0.000 claims description 10
- 230000002141 anti-parasite Effects 0.000 claims description 10
- 238000003205 genotyping method Methods 0.000 claims description 10
- 230000007918 pathogenicity Effects 0.000 claims description 10
- 102000017286 Histone H2A Human genes 0.000 claims description 9
- 108050005231 Histone H2A Proteins 0.000 claims description 9
- 102100021639 Histone H2B type 1-K Human genes 0.000 claims description 9
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims description 9
- 238000007672 fourth generation sequencing Methods 0.000 claims description 9
- 238000012165 high-throughput sequencing Methods 0.000 claims description 9
- 210000002540 macrophage Anatomy 0.000 claims description 9
- 238000007481 next generation sequencing Methods 0.000 claims description 9
- 230000003071 parasitic effect Effects 0.000 claims description 9
- 210000003296 saliva Anatomy 0.000 claims description 9
- 210000001179 synovial fluid Anatomy 0.000 claims description 9
- 210000002700 urine Anatomy 0.000 claims description 9
- 230000003301 hydrolyzing effect Effects 0.000 claims description 8
- 241000283707 Capra Species 0.000 claims description 7
- 241000283073 Equus caballus Species 0.000 claims description 7
- 241000282326 Felis catus Species 0.000 claims description 7
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 7
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims description 7
- 241000283984 Rodentia Species 0.000 claims description 7
- 108020004682 Single-Stranded DNA Proteins 0.000 claims description 7
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical group O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims description 7
- 238000007069 methylation reaction Methods 0.000 claims description 7
- 238000007480 sanger sequencing Methods 0.000 claims description 7
- 102100034533 Histone H2AX Human genes 0.000 claims description 6
- 101710195517 Histone H2AX Proteins 0.000 claims description 6
- 101710103773 Histone H2B Proteins 0.000 claims description 6
- 241001494479 Pecora Species 0.000 claims description 6
- 238000001962 electrophoresis Methods 0.000 claims description 6
- 230000026731 phosphorylation Effects 0.000 claims description 6
- 238000006366 phosphorylation reaction Methods 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- MPNXSZJPSVBLHP-UHFFFAOYSA-N 2-chloro-n-phenylpyridine-3-carboxamide Chemical compound ClC1=NC=CC=C1C(=O)NC1=CC=CC=C1 MPNXSZJPSVBLHP-UHFFFAOYSA-N 0.000 claims description 5
- 108010053770 Deoxyribonucleases Proteins 0.000 claims description 5
- 102000016911 Deoxyribonucleases Human genes 0.000 claims description 5
- 108010072685 Uracil-DNA Glycosidase Proteins 0.000 claims description 5
- 102000006943 Uracil-DNA Glycosidase Human genes 0.000 claims description 5
- 241000251539 Vertebrata <Metazoa> Species 0.000 claims description 4
- 108010036364 Deoxyribonuclease IV (Phage T4-Induced) Proteins 0.000 claims description 3
- 108010064144 endodeoxyribonuclease VII Proteins 0.000 claims description 3
- 238000001114 immunoprecipitation Methods 0.000 claims description 3
- 238000005342 ion exchange Methods 0.000 claims description 3
- 238000002218 isotachophoresis Methods 0.000 claims description 3
- 238000010839 reverse transcription Methods 0.000 claims description 3
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 claims description 2
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 claims description 2
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical group C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 claims description 2
- 239000007850 fluorescent dye Substances 0.000 claims description 2
- 238000007834 ligase chain reaction Methods 0.000 claims description 2
- 230000001404 mediated effect Effects 0.000 claims description 2
- 238000003752 polymerase chain reaction Methods 0.000 claims description 2
- 230000003362 replicative effect Effects 0.000 claims description 2
- 238000013518 transcription Methods 0.000 claims description 2
- 230000035897 transcription Effects 0.000 claims description 2
- 238000012544 monitoring process Methods 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 4
- 201000010099 disease Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 241000894007 species Species 0.000 description 106
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 61
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 39
- 238000009739 binding Methods 0.000 description 33
- 239000000872 buffer Substances 0.000 description 28
- 239000003814 drug Substances 0.000 description 22
- 229940079593 drug Drugs 0.000 description 22
- 230000000670 limiting effect Effects 0.000 description 20
- 239000012634 fragment Substances 0.000 description 19
- 208000015181 infectious disease Diseases 0.000 description 19
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 18
- 239000011324 bead Substances 0.000 description 17
- 238000009396 hybridization Methods 0.000 description 16
- 108091092259 cell-free RNA Proteins 0.000 description 14
- 230000029087 digestion Effects 0.000 description 14
- 238000001514 detection method Methods 0.000 description 13
- -1 non-human Chemical class 0.000 description 13
- 238000005406 washing Methods 0.000 description 12
- 239000012472 biological sample Substances 0.000 description 11
- 238000000926 separation method Methods 0.000 description 11
- 230000006820 DNA synthesis Effects 0.000 description 10
- 102100030690 Histone H2B type 1-C/E/F/G/I Human genes 0.000 description 10
- 102100034535 Histone H3.1 Human genes 0.000 description 10
- 230000004048 modification Effects 0.000 description 10
- 238000012986 modification Methods 0.000 description 10
- 101001084682 Homo sapiens Histone H2B type 1-C/E/F/G/I Proteins 0.000 description 9
- 101001067844 Homo sapiens Histone H3.1 Proteins 0.000 description 9
- 238000013459 approach Methods 0.000 description 9
- 239000012528 membrane Substances 0.000 description 9
- 239000000377 silicon dioxide Substances 0.000 description 9
- 108091093037 Peptide nucleic acid Proteins 0.000 description 8
- 108091092240 circulating cell-free DNA Proteins 0.000 description 8
- 238000001502 gel electrophoresis Methods 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 230000001177 retroviral effect Effects 0.000 description 8
- 238000009738 saturating Methods 0.000 description 8
- 239000011534 wash buffer Substances 0.000 description 8
- 238000001712 DNA sequencing Methods 0.000 description 7
- 102100030649 Histone H2B type 1-J Human genes 0.000 description 7
- 102100039846 Histone H2B type F-M Human genes 0.000 description 7
- 108010090804 Streptavidin Proteins 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 238000005251 capillar electrophoresis Methods 0.000 description 7
- 230000000779 depleting effect Effects 0.000 description 7
- 238000013461 design Methods 0.000 description 7
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 7
- 108020004999 messenger RNA Proteins 0.000 description 7
- 238000010606 normalization Methods 0.000 description 7
- 238000001821 nucleic acid purification Methods 0.000 description 7
- 108090000765 processed proteins & peptides Proteins 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- 241000283690 Bos taurus Species 0.000 description 6
- 241000193163 Clostridioides difficile Species 0.000 description 6
- 208000035473 Communicable disease Diseases 0.000 description 6
- 108010042407 Endonucleases Proteins 0.000 description 6
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 6
- 102100033572 Histone H2B type 2-E Human genes 0.000 description 6
- 241000191967 Staphylococcus aureus Species 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 6
- 238000010804 cDNA synthesis Methods 0.000 description 6
- 238000004587 chromatography analysis Methods 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 6
- 108090001008 Avidin Proteins 0.000 description 5
- 241000588921 Enterobacteriaceae Species 0.000 description 5
- 241000194033 Enterococcus Species 0.000 description 5
- 241000709661 Enterovirus Species 0.000 description 5
- 101710200007 Histone H2A-Bbd type 1 Proteins 0.000 description 5
- 102100030993 Histone H2A-Bbd type 2/3 Human genes 0.000 description 5
- 102100030689 Histone H2B type 1-D Human genes 0.000 description 5
- 102100030650 Histone H2B type 1-H Human genes 0.000 description 5
- 101001035373 Homo sapiens Histone H2B type F-M Proteins 0.000 description 5
- 241000701806 Human papillomavirus Species 0.000 description 5
- 241000124008 Mammalia Species 0.000 description 5
- 241000194017 Streptococcus Species 0.000 description 5
- 108010059993 Vancomycin Proteins 0.000 description 5
- 238000001042 affinity chromatography Methods 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 229960003165 vancomycin Drugs 0.000 description 5
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 5
- 241000589876 Campylobacter Species 0.000 description 4
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 4
- 229930186147 Cephalosporin Natural products 0.000 description 4
- 108091006146 Channels Proteins 0.000 description 4
- 241001115402 Ebolavirus Species 0.000 description 4
- 102100039266 Histone H2A type 1-B/E Human genes 0.000 description 4
- 102100039263 Histone H2A type 1-D Human genes 0.000 description 4
- 102100021642 Histone H2A type 2-A Human genes 0.000 description 4
- 102100023919 Histone H2A.Z Human genes 0.000 description 4
- 102100030688 Histone H2B type 1-A Human genes 0.000 description 4
- 102100021638 Histone H2B type 1-N Human genes 0.000 description 4
- 102100024501 Histone H3-like centromeric protein A Human genes 0.000 description 4
- 102100034536 Histone H3.1t Human genes 0.000 description 4
- 101001084684 Homo sapiens Histone H2B type 1-D Proteins 0.000 description 4
- 101000871966 Homo sapiens Histone H2B type 2-E Proteins 0.000 description 4
- 101001035372 Homo sapiens Histone H2B type F-S Proteins 0.000 description 4
- 241000700588 Human alphaherpesvirus 1 Species 0.000 description 4
- 241000701074 Human alphaherpesvirus 2 Species 0.000 description 4
- 241000701085 Human alphaherpesvirus 3 Species 0.000 description 4
- 241000725303 Human immunodeficiency virus Species 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 241000238070 Pandalus borealis Species 0.000 description 4
- 241000607142 Salmonella Species 0.000 description 4
- 241000607768 Shigella Species 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 229940124587 cephalosporin Drugs 0.000 description 4
- 150000001780 cephalosporins Chemical class 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 102000034287 fluorescent proteins Human genes 0.000 description 4
- 108091006047 fluorescent proteins Proteins 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 238000002493 microarray Methods 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000002096 quantum dot Substances 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- HWPZZUQOWRWFDB-UHFFFAOYSA-N 1-methylcytosine Chemical compound CN1C=CC(N)=NC1=O HWPZZUQOWRWFDB-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- 241000589968 Borrelia Species 0.000 description 3
- 102100034528 Core histone macro-H2A.1 Human genes 0.000 description 3
- 241000711573 Coronaviridae Species 0.000 description 3
- 241000699800 Cricetinae Species 0.000 description 3
- 102000004533 Endonucleases Human genes 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- 101710132521 Histone H2A type 2-A Proteins 0.000 description 3
- 102100027363 Histone H2A type 2-C Human genes 0.000 description 3
- 102100030994 Histone H2A.J Human genes 0.000 description 3
- 101710090917 Histone H2A.J Proteins 0.000 description 3
- 102100030687 Histone H2B type 1-B Human genes 0.000 description 3
- 102100021640 Histone H2B type 1-L Human genes 0.000 description 3
- 102100021637 Histone H2B type 1-M Human genes 0.000 description 3
- 102100021544 Histone H2B type 1-O Human genes 0.000 description 3
- 102100027357 Histone H2B type W-T Human genes 0.000 description 3
- 101710086682 Histone H2B.1 Proteins 0.000 description 3
- 102100038736 Histone H3.3C Human genes 0.000 description 3
- 101001036111 Homo sapiens Histone H2A type 1-B/E Proteins 0.000 description 3
- 101001067850 Homo sapiens Histone H3.1t Proteins 0.000 description 3
- 241000046923 Human bocavirus Species 0.000 description 3
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 3
- 241000342334 Human metapneumovirus Species 0.000 description 3
- 241001115401 Marburgvirus Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 3
- 241000588653 Neisseria Species 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 241001631646 Papillomaviridae Species 0.000 description 3
- 241001480233 Paragonimus Species 0.000 description 3
- 102100030989 Putative histone H2B type 2-C Human genes 0.000 description 3
- 241000725643 Respiratory syncytial virus Species 0.000 description 3
- 241000191940 Staphylococcus Species 0.000 description 3
- 241000193998 Streptococcus pneumoniae Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 239000012148 binding buffer Substances 0.000 description 3
- 239000008366 buffered solution Substances 0.000 description 3
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical compound C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 description 3
- 230000003196 chaotropic effect Effects 0.000 description 3
- 230000009089 cytolysis Effects 0.000 description 3
- 239000003398 denaturant Substances 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 229960003276 erythromycin Drugs 0.000 description 3
- 230000002621 immunoprecipitating effect Effects 0.000 description 3
- 230000002458 infectious effect Effects 0.000 description 3
- 229960003085 meticillin Drugs 0.000 description 3
- 108091070501 miRNA Proteins 0.000 description 3
- 239000002679 microRNA Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 125000006850 spacer group Chemical group 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000008685 targeting Effects 0.000 description 3
- 241001529453 unidentified herpesvirus Species 0.000 description 3
- 241001430294 unidentified retrovirus Species 0.000 description 3
- 241000589291 Acinetobacter Species 0.000 description 2
- 241000701242 Adenoviridae Species 0.000 description 2
- 241000712892 Arenaviridae Species 0.000 description 2
- 241000244185 Ascaris lumbricoides Species 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 2
- 241001533362 Astroviridae Species 0.000 description 2
- 241001516406 Avian orthoreovirus Species 0.000 description 2
- 241000589562 Brucella Species 0.000 description 2
- 241000244038 Brugia malayi Species 0.000 description 2
- 241000714198 Caliciviridae Species 0.000 description 2
- 108010076303 Centromere Protein A Proteins 0.000 description 2
- 241000606161 Chlamydia Species 0.000 description 2
- 241000606153 Chlamydia trachomatis Species 0.000 description 2
- 241001327965 Clonorchis sinensis Species 0.000 description 2
- 241000193403 Clostridium Species 0.000 description 2
- 241000193468 Clostridium perfringens Species 0.000 description 2
- 208000003322 Coinfection Diseases 0.000 description 2
- 241000204955 Colorado tick fever virus Species 0.000 description 2
- 108091029523 CpG island Proteins 0.000 description 2
- 241000150230 Crimean-Congo hemorrhagic fever orthonairovirus Species 0.000 description 2
- 241000223935 Cryptosporidium Species 0.000 description 2
- 241000701022 Cytomegalovirus Species 0.000 description 2
- 108090000204 Dipeptidase 1 Proteins 0.000 description 2
- 101001084710 Drosophila melanogaster Histone H2A.v Proteins 0.000 description 2
- 101100310856 Drosophila melanogaster spri gene Proteins 0.000 description 2
- 108010067770 Endopeptidase K Proteins 0.000 description 2
- 241000224432 Entamoeba histolytica Species 0.000 description 2
- 241001529459 Enterovirus A71 Species 0.000 description 2
- 241000991587 Enterovirus C Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000711950 Filoviridae Species 0.000 description 2
- 241000710781 Flaviviridae Species 0.000 description 2
- 241000224467 Giardia intestinalis Species 0.000 description 2
- 241000190708 Guanarito mammarenavirus Species 0.000 description 2
- 241000711549 Hepacivirus C Species 0.000 description 2
- 241000700739 Hepadnaviridae Species 0.000 description 2
- 241000700721 Hepatitis B virus Species 0.000 description 2
- 241000724675 Hepatitis E virus Species 0.000 description 2
- 241000709721 Hepatovirus A Species 0.000 description 2
- 241001122120 Hepeviridae Species 0.000 description 2
- 241000700586 Herpesviridae Species 0.000 description 2
- 102100039268 Histone H2A type 1-A Human genes 0.000 description 2
- 102100039271 Histone H2A type 1-H Human genes 0.000 description 2
- 102100039269 Histone H2A type 1-J Human genes 0.000 description 2
- 101710090602 Histone H2A.1 Proteins 0.000 description 2
- 101710090606 Histone H2A.2 Proteins 0.000 description 2
- 102100030673 Histone H2A.V Human genes 0.000 description 2
- 101710090643 Histone H2A.V Proteins 0.000 description 2
- 101710090647 Histone H2A.Z Proteins 0.000 description 2
- 101710160686 Histone H2B type 1-H Proteins 0.000 description 2
- 101710160681 Histone H2B type 1-J Proteins 0.000 description 2
- 101710160689 Histone H2B type 1-K Proteins 0.000 description 2
- 101710160674 Histone H2B type 1-N Proteins 0.000 description 2
- 101710162048 Histone H2B type 2-E Proteins 0.000 description 2
- 102100038806 Histone H2B type 3-B Human genes 0.000 description 2
- 101710113261 Histone H2B type F-M Proteins 0.000 description 2
- 101710195387 Histone H3.2 Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 101001036112 Homo sapiens Histone H2A type 1-D Proteins 0.000 description 2
- 101001009465 Homo sapiens Histone H2A type 2-C Proteins 0.000 description 2
- 101000905054 Homo sapiens Histone H2A.Z Proteins 0.000 description 2
- 101001084688 Homo sapiens Histone H2B type 1-A Proteins 0.000 description 2
- 101001084691 Homo sapiens Histone H2B type 1-B Proteins 0.000 description 2
- 101001084676 Homo sapiens Histone H2B type 1-H Proteins 0.000 description 2
- 101001084678 Homo sapiens Histone H2B type 1-J Proteins 0.000 description 2
- 101000898901 Homo sapiens Histone H2B type 1-L Proteins 0.000 description 2
- 101000898894 Homo sapiens Histone H2B type 1-M Proteins 0.000 description 2
- 101000898897 Homo sapiens Histone H2B type 1-N Proteins 0.000 description 2
- 101000898881 Homo sapiens Histone H2B type 1-O Proteins 0.000 description 2
- 101001009399 Homo sapiens Histone H2B type W-T Proteins 0.000 description 2
- 101000871895 Homo sapiens Histone H3.2 Proteins 0.000 description 2
- 101001031505 Homo sapiens Histone H3.3C Proteins 0.000 description 2
- 101001067880 Homo sapiens Histone H4 Proteins 0.000 description 2
- 101000843289 Homo sapiens Putative histone H2B type 2-C Proteins 0.000 description 2
- 101000843169 Homo sapiens Putative histone H2B type 2-D Proteins 0.000 description 2
- 241000701041 Human betaherpesvirus 7 Species 0.000 description 2
- 241000701027 Human herpesvirus 6 Species 0.000 description 2
- 241000702617 Human parvovirus B19 Species 0.000 description 2
- 241000829111 Human polyomavirus 1 Species 0.000 description 2
- 241000701460 JC polyomavirus Species 0.000 description 2
- 241000712890 Junin mammarenavirus Species 0.000 description 2
- 241000712902 Lassa mammarenavirus Species 0.000 description 2
- 241000589902 Leptospira Species 0.000 description 2
- 241000439489 Lloviu cuevavirus Species 0.000 description 2
- 208000016604 Lyme disease Diseases 0.000 description 2
- 241000712899 Lymphocytic choriomeningitis mammarenavirus Species 0.000 description 2
- 241000712898 Machupo mammarenavirus Species 0.000 description 2
- 108010033834 McrBC endonuclease Proteins 0.000 description 2
- 241000712079 Measles morbillivirus Species 0.000 description 2
- 241000127282 Middle East respiratory syndrome-related coronavirus Species 0.000 description 2
- 241000700560 Molluscum contagiosum virus Species 0.000 description 2
- 241000700627 Monkeypox virus Species 0.000 description 2
- 241000711386 Mumps virus Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 208000008756 Mycetoma Diseases 0.000 description 2
- 241000588652 Neisseria gonorrhoeae Species 0.000 description 2
- 241000712464 Orthomyxoviridae Species 0.000 description 2
- 241000711504 Paramyxoviridae Species 0.000 description 2
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 2
- 241000701945 Parvoviridae Species 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 241000150350 Peribunyaviridae Species 0.000 description 2
- 241000009328 Perro Species 0.000 description 2
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 2
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 2
- 241001631648 Polyomaviridae Species 0.000 description 2
- 241000700625 Poxviridae Species 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 241000517304 Pthirus pubis Species 0.000 description 2
- 238000003559 RNA-seq method Methods 0.000 description 2
- 241000711798 Rabies lyssavirus Species 0.000 description 2
- 241000702247 Reoviridae Species 0.000 description 2
- 241000712907 Retroviridae Species 0.000 description 2
- 241000711931 Rhabdoviridae Species 0.000 description 2
- 241000606701 Rickettsia Species 0.000 description 2
- 241000702670 Rotavirus Species 0.000 description 2
- 241000710799 Rubella virus Species 0.000 description 2
- 241000315672 SARS coronavirus Species 0.000 description 2
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 2
- 241000242678 Schistosoma Species 0.000 description 2
- 241000150288 Sin Nombre orthohantavirus Species 0.000 description 2
- 208000001203 Smallpox Diseases 0.000 description 2
- 201000005010 Streptococcus pneumonia Diseases 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 241001115374 Tai Forest ebolavirus Species 0.000 description 2
- 239000004098 Tetracycline Chemical class 0.000 description 2
- 241000710924 Togaviridae Species 0.000 description 2
- 241000223229 Trichophyton rubrum Species 0.000 description 2
- 241001489145 Trichuris trichiura Species 0.000 description 2
- 241000710886 West Nile virus Species 0.000 description 2
- 241000244005 Wuchereria bancrofti Species 0.000 description 2
- 241000710772 Yellow fever virus Species 0.000 description 2
- 206010061418 Zygomycosis Diseases 0.000 description 2
- 108700010877 adenoviridae proteins Proteins 0.000 description 2
- 229940126575 aminoglycoside Drugs 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 239000003443 antiviral agent Substances 0.000 description 2
- 102000006635 beta-lactamase Human genes 0.000 description 2
- 230000006287 biotinylation Effects 0.000 description 2
- 238000007413 biotinylation Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229940038705 chlamydia trachomatis Drugs 0.000 description 2
- 229960002227 clindamycin Drugs 0.000 description 2
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 208000015355 drug-resistant tuberculosis Diseases 0.000 description 2
- 229940007078 entamoeba histolytica Drugs 0.000 description 2
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 2
- 229960004884 fluconazole Drugs 0.000 description 2
- 229940124307 fluoroquinolone Drugs 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 108010064151 histone H2B type 1-A Proteins 0.000 description 2
- 238000003318 immunodepletion Methods 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 201000006747 infectious mononucleosis Diseases 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 201000009671 multidrug-resistant tuberculosis Diseases 0.000 description 2
- 238000007899 nucleic acid hybridization Methods 0.000 description 2
- 239000013610 patient sample Substances 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000004153 renaturation Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000001847 surface plasmon resonance imaging Methods 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Chemical class 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 241000701161 unidentified adenovirus Species 0.000 description 2
- 229940051021 yellow-fever virus Drugs 0.000 description 2
- 150000003952 β-lactams Chemical class 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- 108020004463 18S ribosomal RNA Proteins 0.000 description 1
- JTBBWRKSUYCPFY-UHFFFAOYSA-N 2,3-dihydro-1h-pyrimidin-4-one Chemical class O=C1NCNC=C1 JTBBWRKSUYCPFY-UHFFFAOYSA-N 0.000 description 1
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 description 1
- 108020005096 28S Ribosomal RNA Proteins 0.000 description 1
- RYSMHWILUNYBFW-GRIPGOBMSA-N 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine Chemical compound C1=NC=2C(N(C)C)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](N)[C@H]1O RYSMHWILUNYBFW-GRIPGOBMSA-N 0.000 description 1
- QWZHDKGQKYEBKK-UHFFFAOYSA-N 3-aminochromen-2-one Chemical compound C1=CC=C2OC(=O)C(N)=CC2=C1 QWZHDKGQKYEBKK-UHFFFAOYSA-N 0.000 description 1
- XHCNINMOALIGKM-UHFFFAOYSA-N 5,5,7,12,12,14-hexamethyl-1,4,8,11-tetrazacyclotetradecane Chemical compound CC1CC(C)(C)NCCNC(C)CC(C)(C)NCCN1 XHCNINMOALIGKM-UHFFFAOYSA-N 0.000 description 1
- 208000035657 Abasia Diseases 0.000 description 1
- 241000224422 Acanthamoeba Species 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- 241000588626 Acinetobacter baumannii Species 0.000 description 1
- 241000511654 Actinomyces gerencseriae Species 0.000 description 1
- 241000186041 Actinomyces israelii Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000710929 Alphavirus Species 0.000 description 1
- 102100034452 Alternative prion protein Human genes 0.000 description 1
- 241000007422 Amur virus Species 0.000 description 1
- 241000606646 Anaplasma Species 0.000 description 1
- 241000605281 Anaplasma phagocytophilum Species 0.000 description 1
- 241001511271 Ancylostoma braziliense Species 0.000 description 1
- 241000498253 Ancylostoma duodenale Species 0.000 description 1
- 241000150489 Andes orthohantavirus Species 0.000 description 1
- 241001339993 Anelloviridae Species 0.000 description 1
- 241000359199 Angiostrongylus costaricensis Species 0.000 description 1
- 241000244023 Anisakis Species 0.000 description 1
- 241001135700 Arcanobacterium haemolyticum Species 0.000 description 1
- 241000203069 Archaea Species 0.000 description 1
- 241000700607 Archiacanthocephala Species 0.000 description 1
- 241000238888 Argasidae Species 0.000 description 1
- 241000796533 Arna Species 0.000 description 1
- 241001126258 Ascaris sp. Species 0.000 description 1
- 241000807593 Avian nephritis virus Species 0.000 description 1
- 241000223836 Babesia Species 0.000 description 1
- 241000223840 Babesia bigemina Species 0.000 description 1
- 241001455947 Babesia divergens Species 0.000 description 1
- 241001648338 Babesia duncani Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 108020000946 Bacterial DNA Proteins 0.000 description 1
- 241000606125 Bacteroides Species 0.000 description 1
- 241000934146 Balamuthia mandrillaris Species 0.000 description 1
- 241001235572 Balantioides coli Species 0.000 description 1
- 241001302512 Banna virus Species 0.000 description 1
- 241001518086 Bartonella henselae Species 0.000 description 1
- 241000217815 Bas-Congo tibrovirus Species 0.000 description 1
- 241000244181 Baylisascaris Species 0.000 description 1
- 241000244183 Baylisascaris procyonis Species 0.000 description 1
- 241001284802 Bertiella <tapeworm> Species 0.000 description 1
- 241001284800 Bertiella studeri Species 0.000 description 1
- 241000726108 Blastocystis Species 0.000 description 1
- 241000726107 Blastocystis hominis Species 0.000 description 1
- 241000228405 Blastomyces dermatitidis Species 0.000 description 1
- 241001242440 Blueberry shock virus Species 0.000 description 1
- 241000588807 Bordetella Species 0.000 description 1
- 241000588832 Bordetella pertussis Species 0.000 description 1
- 241000589969 Borreliella burgdorferi Species 0.000 description 1
- 241000711443 Bovine coronavirus Species 0.000 description 1
- 241000701066 Bovine gammaherpesvirus 4 Species 0.000 description 1
- 241000701922 Bovine parvovirus Species 0.000 description 1
- 241000143302 Brugia timori Species 0.000 description 1
- 241001218594 Bulbul coronavirus HKU11 Species 0.000 description 1
- 241001453380 Burkholderia Species 0.000 description 1
- 241000589513 Burkholderia cepacia Species 0.000 description 1
- 241000722910 Burkholderia mallei Species 0.000 description 1
- 241001136175 Burkholderia pseudomallei Species 0.000 description 1
- 101150038588 CHRNB1 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000257161 Calliphoridae Species 0.000 description 1
- 101100476566 Campylobacter jejuni aad9 gene Proteins 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 241001507540 Carrizal virus Species 0.000 description 1
- 241000709807 Catacamas virus Species 0.000 description 1
- 241000242722 Cestoda Species 0.000 description 1
- 241000711969 Chandipura virus Species 0.000 description 1
- 241000725585 Chicken anemia virus Species 0.000 description 1
- 241001647372 Chlamydia pneumoniae Species 0.000 description 1
- 241001647378 Chlamydia psittaci Species 0.000 description 1
- 206010061041 Chlamydial infection Diseases 0.000 description 1
- 241000430977 Choclo virus Species 0.000 description 1
- 241001327638 Cimex lectularius Species 0.000 description 1
- 241001327942 Clonorchis Species 0.000 description 1
- 241000193155 Clostridium botulinum Species 0.000 description 1
- 241000193449 Clostridium tetani Species 0.000 description 1
- 241000223205 Coccidioides immitis Species 0.000 description 1
- 241001522757 Coccidioides posadasii Species 0.000 description 1
- 241000202814 Cochliomyia hominivorax Species 0.000 description 1
- 241000702669 Coltivirus Species 0.000 description 1
- 102000017634 Core histone macro-H2A Human genes 0.000 description 1
- 108050005899 Core histone macro-H2A Proteins 0.000 description 1
- 101710184999 Core histone macro-H2A.1 Proteins 0.000 description 1
- 102100030670 Core histone macro-H2A.2 Human genes 0.000 description 1
- 101710185000 Core histone macro-H2A.2 Proteins 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
- 241000606678 Coxiella burnetii Species 0.000 description 1
- 241000709687 Coxsackievirus Species 0.000 description 1
- 241000710127 Cricket paralysis virus Species 0.000 description 1
- 201000007336 Cryptococcosis Diseases 0.000 description 1
- 241001527609 Cryptococcus Species 0.000 description 1
- 241000221204 Cryptococcus neoformans Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000256057 Culex quinquefasciatus Species 0.000 description 1
- 241000016605 Cyclospora cayetanensis Species 0.000 description 1
- 241001051708 Cyprinid herpesvirus 3 Species 0.000 description 1
- 201000003808 Cystic echinococcosis Diseases 0.000 description 1
- 241000205707 Cystoisospora belli Species 0.000 description 1
- 230000030933 DNA methylation on cytosine Effects 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 241001218273 Demodex brevis Species 0.000 description 1
- 241000193880 Demodex folliculorum Species 0.000 description 1
- 241000725619 Dengue virus Species 0.000 description 1
- 241000710829 Dengue virus group Species 0.000 description 1
- 241000202828 Dermatobia hominis Species 0.000 description 1
- 241000577456 Dicrocoelium dendriticum Species 0.000 description 1
- 241000157306 Dientamoeba fragilis Species 0.000 description 1
- 241000690786 Dioctophyme renale Species 0.000 description 1
- 241001137876 Diphyllobothrium Species 0.000 description 1
- 241000866683 Diphyllobothrium latum Species 0.000 description 1
- 241000150528 Dobrava-Belgrade orthohantavirus Species 0.000 description 1
- 241001319090 Dracunculus medinensis Species 0.000 description 1
- 101150105814 ERMN gene Proteins 0.000 description 1
- 201000011001 Ebola Hemorrhagic Fever Diseases 0.000 description 1
- 241000244160 Echinococcus Species 0.000 description 1
- 241000244170 Echinococcus granulosus Species 0.000 description 1
- 241000244163 Echinococcus multilocularis Species 0.000 description 1
- 241000244162 Echinococcus oligarthrus Species 0.000 description 1
- 241000244165 Echinococcus vogeli Species 0.000 description 1
- 241000605314 Ehrlichia Species 0.000 description 1
- 241000605310 Ehrlichia chaffeensis Species 0.000 description 1
- 241000605282 Ehrlichia ewingii Species 0.000 description 1
- 241000150534 El Moro Canyon orthohantavirus Species 0.000 description 1
- 241000498256 Enterobius Species 0.000 description 1
- 241000498255 Enterobius vermicularis Species 0.000 description 1
- 101100476567 Enterococcus faecalis spc gene Proteins 0.000 description 1
- 241000235577 Entomophthorales Species 0.000 description 1
- 206010066919 Epidemic polyarthritis Diseases 0.000 description 1
- 241001480036 Epidermophyton floccosum Species 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241001646719 Escherichia coli O157:H7 Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 241000204939 Fasciola gigantica Species 0.000 description 1
- 241000242711 Fasciola hepatica Species 0.000 description 1
- 241001126302 Fasciolopsis buski Species 0.000 description 1
- 241000714165 Feline leukemia virus Species 0.000 description 1
- 241000239183 Filaria Species 0.000 description 1
- 241000244009 Filarioidea Species 0.000 description 1
- 241000710831 Flavivirus Species 0.000 description 1
- 241000122864 Fonsecaea pedrosoi Species 0.000 description 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
- 241000589601 Francisella Species 0.000 description 1
- 241000589602 Francisella tularensis Species 0.000 description 1
- 241000605909 Fusobacterium Species 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 244000168141 Geotrichum candidum Species 0.000 description 1
- 235000017388 Geotrichum candidum Nutrition 0.000 description 1
- 241000497087 Gnathostoma hispidum Species 0.000 description 1
- 241001276383 Gnathostoma spinigerum Species 0.000 description 1
- 241000545372 Gou virus Species 0.000 description 1
- 208000031886 HIV Infections Diseases 0.000 description 1
- 208000037357 HIV infectious disease Diseases 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 101100077927 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) mrdA gene Proteins 0.000 description 1
- 241000196812 Halicephalobus gingivalis Species 0.000 description 1
- 241001335250 Heartland virus Species 0.000 description 1
- 241000589989 Helicobacter Species 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 241000893570 Hendra henipavirus Species 0.000 description 1
- 241000035314 Henipavirus Species 0.000 description 1
- 208000005331 Hepatitis D Diseases 0.000 description 1
- 208000037262 Hepatitis delta Diseases 0.000 description 1
- 241000724709 Hepatitis delta virus Species 0.000 description 1
- 101710192083 Histone H1.0 Proteins 0.000 description 1
- 102100037487 Histone H1.0 Human genes 0.000 description 1
- 101710102376 Histone H2A type 1 Proteins 0.000 description 1
- 101710132529 Histone H2A type 1-A Proteins 0.000 description 1
- 101710104855 Histone H2A type 1-B/E Proteins 0.000 description 1
- 102100039265 Histone H2A type 1-C Human genes 0.000 description 1
- 101710132515 Histone H2A type 1-C Proteins 0.000 description 1
- 101710132512 Histone H2A type 1-D Proteins 0.000 description 1
- 101710132518 Histone H2A type 1-H Proteins 0.000 description 1
- 101710132336 Histone H2A type 1-J Proteins 0.000 description 1
- 102100021643 Histone H2A type 2-B Human genes 0.000 description 1
- 101710132522 Histone H2A type 2-B Proteins 0.000 description 1
- 101710132524 Histone H2A type 2-C Proteins 0.000 description 1
- 102100038807 Histone H2A type 3 Human genes 0.000 description 1
- 101710102380 Histone H2A type 3 Proteins 0.000 description 1
- 102100033550 Histone H2A-Bbd type 1 Human genes 0.000 description 1
- 101710176360 Histone H2A-Bbd type 2/3 Proteins 0.000 description 1
- 101710090646 Histone H2A.Y Proteins 0.000 description 1
- 101710160685 Histone H2B type 1-B Proteins 0.000 description 1
- 101710120066 Histone H2B type 1-C/E/F/G/I Proteins 0.000 description 1
- 101710160680 Histone H2B type 1-D Proteins 0.000 description 1
- 101710160673 Histone H2B type 1-L Proteins 0.000 description 1
- 101710160675 Histone H2B type 1-M Proteins 0.000 description 1
- 101710162046 Histone H2B type 2-F Proteins 0.000 description 1
- 101710163832 Histone H2B type 3-B Proteins 0.000 description 1
- 102100039869 Histone H2B type F-S Human genes 0.000 description 1
- 101710113266 Histone H2B type F-S Proteins 0.000 description 1
- 101710164968 Histone H2B type W-T Proteins 0.000 description 1
- 101710086625 Histone H2B.2 Proteins 0.000 description 1
- 101710125136 Histone H3-like centromeric protein A Proteins 0.000 description 1
- 101710195388 Histone H3.1 Proteins 0.000 description 1
- 101710195400 Histone H3.3 Proteins 0.000 description 1
- 101710159094 Histone H3.3C Proteins 0.000 description 1
- 101710195395 Histone H3.4 Proteins 0.000 description 1
- 102100023847 Histone H3.X Human genes 0.000 description 1
- 101710195430 Histone H3.X Proteins 0.000 description 1
- 101710195427 Histone H3.Y Proteins 0.000 description 1
- 102100023848 Histone H3.Y Human genes 0.000 description 1
- 102100034523 Histone H4 Human genes 0.000 description 1
- 102100021489 Histone H4-like protein type G Human genes 0.000 description 1
- 101710149667 Histone H4-like protein type G Proteins 0.000 description 1
- 241000228402 Histoplasma Species 0.000 description 1
- 241000228404 Histoplasma capsulatum Species 0.000 description 1
- 101000924727 Homo sapiens Alternative prion protein Proteins 0.000 description 1
- 101000777370 Homo sapiens Coiled-coil domain-containing protein 6 Proteins 0.000 description 1
- 101001067929 Homo sapiens Core histone macro-H2A.1 Proteins 0.000 description 1
- 101000827746 Homo sapiens Fibroblast growth factor receptor 1 Proteins 0.000 description 1
- 101001035431 Homo sapiens Histone H2A type 1 Proteins 0.000 description 1
- 101001036104 Homo sapiens Histone H2A type 1-A Proteins 0.000 description 1
- 101001036100 Homo sapiens Histone H2A type 1-H Proteins 0.000 description 1
- 101001036102 Homo sapiens Histone H2A type 1-J Proteins 0.000 description 1
- 101000898905 Homo sapiens Histone H2A type 2-A Proteins 0.000 description 1
- 101000898898 Homo sapiens Histone H2B type 1-K Proteins 0.000 description 1
- 101001031390 Homo sapiens Histone H2B type 3-B Proteins 0.000 description 1
- 101000981071 Homo sapiens Histone H3-like centromeric protein A Proteins 0.000 description 1
- 101000573901 Homo sapiens Major prion protein Proteins 0.000 description 1
- 101000843236 Homo sapiens Testis-specific H1 histone Proteins 0.000 description 1
- 241000308509 Hortaea Species 0.000 description 1
- 241001479210 Human astrovirus Species 0.000 description 1
- 241000701024 Human betaherpesvirus 5 Species 0.000 description 1
- 206010020429 Human ehrlichiosis Diseases 0.000 description 1
- 241000244166 Hymenolepis diminuta Species 0.000 description 1
- 241001464384 Hymenolepis nana Species 0.000 description 1
- 241000700723 Ictalurid herpesvirus 1 Species 0.000 description 1
- 241001179548 Imjin virus Species 0.000 description 1
- 241000142710 Isla Vista hantavirus Species 0.000 description 1
- 206010023076 Isosporiasis Diseases 0.000 description 1
- 241000238889 Ixodidae Species 0.000 description 1
- 241000150551 Khabarovsk orthohantavirus Species 0.000 description 1
- 241000589014 Kingella kingae Species 0.000 description 1
- 241001534216 Klebsiella granulomatis Species 0.000 description 1
- 241000710912 Kunjin virus Species 0.000 description 1
- 241000589248 Legionella Species 0.000 description 1
- 241000589242 Legionella pneumophila Species 0.000 description 1
- 208000007764 Legionnaires' Disease Diseases 0.000 description 1
- 241000222722 Leishmania <genus> Species 0.000 description 1
- 241000713666 Lentivirus Species 0.000 description 1
- 240000000759 Lepidium meyenii Species 0.000 description 1
- 235000000421 Lepidium meyenii Nutrition 0.000 description 1
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 description 1
- 241000995714 Limestone Canyon virus Species 0.000 description 1
- 241001541122 Linguatula serrata Species 0.000 description 1
- 108010028921 Lipopeptides Proteins 0.000 description 1
- 241000186781 Listeria Species 0.000 description 1
- 241000186779 Listeria monocytogenes Species 0.000 description 1
- 241000255640 Loa loa Species 0.000 description 1
- 241000406668 Loxodonta cyclotis Species 0.000 description 1
- 241001573276 Lujo mammarenavirus Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000555676 Malassezia Species 0.000 description 1
- 241000022705 Mansonella streptocerca Species 0.000 description 1
- 241000711937 Marburg marburgvirus Species 0.000 description 1
- 241001643857 Menangle virus Species 0.000 description 1
- 241001660197 Metagonimus Species 0.000 description 1
- 241000243190 Microsporidia Species 0.000 description 1
- 241000008902 Miniopterus bat coronavirus 1 Species 0.000 description 1
- 241000008903 Miniopterus bat coronavirus HKU8 Species 0.000 description 1
- 241000700602 Moniliformis moniliformis Species 0.000 description 1
- 241000235388 Mucorales Species 0.000 description 1
- 241000670735 Muju virus Species 0.000 description 1
- 101100406473 Mus musculus Oprm1 gene Proteins 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 241000186362 Mycobacterium leprae Species 0.000 description 1
- 241000178382 Mycobacterium lepromatosis Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 241000187917 Mycobacterium ulcerans Species 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 1
- 241000224438 Naegleria fowleri Species 0.000 description 1
- 241000498270 Necator americanus Species 0.000 description 1
- 241000588650 Neisseria meningitidis Species 0.000 description 1
- 241000526636 Nipah henipavirus Species 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 241000187678 Nocardia asteroides Species 0.000 description 1
- 241000714209 Norwalk virus Species 0.000 description 1
- 241000158589 Oestroidea Species 0.000 description 1
- 241000243985 Onchocerca volvulus Species 0.000 description 1
- 241001324821 Opisthorchis felineus Species 0.000 description 1
- 241000242726 Opisthorchis viverrini Species 0.000 description 1
- 241000702259 Orbivirus Species 0.000 description 1
- 241000150452 Orthohantavirus Species 0.000 description 1
- 241000526686 Paracoccidioides brasiliensis Species 0.000 description 1
- 241000057252 Paragonimus africanus Species 0.000 description 1
- 241000551217 Paragonimus caliensis Species 0.000 description 1
- 241001446258 Paragonimus kellicotti Species 0.000 description 1
- 241001480234 Paragonimus westermani Species 0.000 description 1
- 241000238124 Paralithodes camtschaticus Species 0.000 description 1
- 241000606860 Pasteurella Species 0.000 description 1
- 241000517306 Pediculus humanus corporis Species 0.000 description 1
- DYUQAZSOFZSPHD-UHFFFAOYSA-N Phenylpropanol Chemical compound CCC(O)C1=CC=CC=C1 DYUQAZSOFZSPHD-UHFFFAOYSA-N 0.000 description 1
- 241000702656 Phytoreovirus Species 0.000 description 1
- 241001326499 Piedraia hortae Species 0.000 description 1
- 241000008909 Pipistrellus bat coronavirus HKU5 Species 0.000 description 1
- 241000224016 Plasmodium Species 0.000 description 1
- 241000223960 Plasmodium falciparum Species 0.000 description 1
- 241000223801 Plasmodium knowlesi Species 0.000 description 1
- 241000223821 Plasmodium malariae Species 0.000 description 1
- 241001675579 Plasmodium ovale curtisi Species 0.000 description 1
- 241001675578 Plasmodium ovale wallikeri Species 0.000 description 1
- 241000223810 Plasmodium vivax Species 0.000 description 1
- ZRZNJUXESFHSIO-UHFFFAOYSA-N Pleuromutilin Natural products CC1C(O)C(C)(C=C)CC(OC(=O)CO)C2(C)C(C)CCC31C2C(=O)CC3 ZRZNJUXESFHSIO-UHFFFAOYSA-N 0.000 description 1
- 241000233870 Pneumocystis Species 0.000 description 1
- 241000142787 Pneumocystis jirovecii Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 108010040201 Polymyxins Proteins 0.000 description 1
- 241000188845 Porcine adenovirus Species 0.000 description 1
- 241000605861 Prevotella Species 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- 102000029797 Prion Human genes 0.000 description 1
- 241000150258 Prospect Hill orthohantavirus Species 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000186336 Pseudopropionibacterium propionicum Species 0.000 description 1
- 241000718000 Pulex irritans Species 0.000 description 1
- 101710109230 Putative histone H2B type 2-C Proteins 0.000 description 1
- 102100031032 Putative histone H2B type 2-D Human genes 0.000 description 1
- 101710109232 Putative histone H2B type 2-D Proteins 0.000 description 1
- 241000149822 Qalyub orthonairovirus Species 0.000 description 1
- 241000712909 Reticuloendotheliosis virus Species 0.000 description 1
- 241000004178 Rhinolophus bat coronavirus HKU2 Species 0.000 description 1
- 241000293824 Rhinosporidium seeberi Species 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 241000606723 Rickettsia akari Species 0.000 description 1
- 241000606697 Rickettsia prowazekii Species 0.000 description 1
- 241000606695 Rickettsia rickettsii Species 0.000 description 1
- 241000606726 Rickettsia typhi Species 0.000 description 1
- 229930189077 Rifamycin Natural products 0.000 description 1
- 241000713124 Rift Valley fever virus Species 0.000 description 1
- 235000011449 Rosa Nutrition 0.000 description 1
- 241000122129 Roseolovirus Species 0.000 description 1
- 241000710942 Ross River virus Species 0.000 description 1
- 241000008907 Rousettus bat coronavirus HKU9 Species 0.000 description 1
- 101150071725 SMDT1 gene Proteins 0.000 description 1
- 241000057035 Saaremaa hantavirus Species 0.000 description 1
- 241000736032 Sabia <angiosperm> Species 0.000 description 1
- 241000192617 Sabia mammarenavirus Species 0.000 description 1
- 241000607361 Salmonella enterica subsp. enterica Species 0.000 description 1
- 241000150272 Sangassou orthohantavirus Species 0.000 description 1
- 241000224003 Sarcocystis Species 0.000 description 1
- 241001473628 Sarcocystis suihominis Species 0.000 description 1
- 241000257185 Sarcophagidae Species 0.000 description 1
- 241000509427 Sarcoptes scabiei Species 0.000 description 1
- 241000242683 Schistosoma haematobium Species 0.000 description 1
- 241000242687 Schistosoma intercalatum Species 0.000 description 1
- 241000242677 Schistosoma japonicum Species 0.000 description 1
- 241000242680 Schistosoma mansoni Species 0.000 description 1
- 241001520868 Schistosoma mekongi Species 0.000 description 1
- 241001442514 Schistosomatidae Species 0.000 description 1
- 101000898919 Schizosaccharomyces pombe (strain 972 / ATCC 24843) Histone H2A-alpha Proteins 0.000 description 1
- 101100054091 Schizosaccharomyces pombe (strain 972 / ATCC 24843) par2 gene Proteins 0.000 description 1
- 241000004179 Scotophilus bat coronavirus 512 Species 0.000 description 1
- 108091061939 Selfish DNA Proteins 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241001108540 Serang virus Species 0.000 description 1
- 241000713656 Simian foamy virus Species 0.000 description 1
- 241000825010 Soochong virus Species 0.000 description 1
- 241000422838 Spirometra erinaceieuropaei Species 0.000 description 1
- 244000025012 Spondias pinnata Species 0.000 description 1
- 235000005658 Spondias pinnata Nutrition 0.000 description 1
- 241001149963 Sporothrix schenckii Species 0.000 description 1
- 241001279361 Stachybotrys Species 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 241000193985 Streptococcus agalactiae Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 241001505901 Streptococcus sp. 'group A' Species 0.000 description 1
- 108010034396 Streptogramins Proteins 0.000 description 1
- 241000244177 Strongyloides stercoralis Species 0.000 description 1
- 241001115376 Sudan ebolavirus Species 0.000 description 1
- 241000244155 Taenia Species 0.000 description 1
- 241000356560 Taenia multiceps Species 0.000 description 1
- 241000244159 Taenia saginata Species 0.000 description 1
- 241000244157 Taenia solium Species 0.000 description 1
- 241001369969 Tanganya virus Species 0.000 description 1
- 241001477954 Thelazia Species 0.000 description 1
- 241001477955 Thelazia callipaeda Species 0.000 description 1
- WKDDRNSBRWANNC-UHFFFAOYSA-N Thienamycin Natural products C1C(SCCN)=C(C(O)=O)N2C(=O)C(C(O)C)C21 WKDDRNSBRWANNC-UHFFFAOYSA-N 0.000 description 1
- 241000150291 Thottapalayam orthohantavirus Species 0.000 description 1
- 241001645339 Topografov hantavirus Species 0.000 description 1
- 241000244030 Toxocara canis Species 0.000 description 1
- 241000244020 Toxocara cati Species 0.000 description 1
- 241000223997 Toxoplasma gondii Species 0.000 description 1
- 241001365589 Tremovirus Species 0.000 description 1
- 241000589886 Treponema Species 0.000 description 1
- 241000589884 Treponema pallidum Species 0.000 description 1
- 241000194297 Trichinella britovi Species 0.000 description 1
- 241000243776 Trichinella nativa Species 0.000 description 1
- 241000243779 Trichinella nelsoni Species 0.000 description 1
- 241000243777 Trichinella spiralis Species 0.000 description 1
- 241000031115 Trichobilharzia regenti Species 0.000 description 1
- 241000224527 Trichomonas vaginalis Species 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 241001045770 Trichophyton mentagrophytes Species 0.000 description 1
- 241001480048 Trichophyton tonsurans Species 0.000 description 1
- 241000223231 Trichosporon beigelii Species 0.000 description 1
- 241001638368 Trichuris vulpis Species 0.000 description 1
- 241000223105 Trypanosoma brucei Species 0.000 description 1
- 241000223109 Trypanosoma cruzi Species 0.000 description 1
- 241000150289 Tula orthohantavirus Species 0.000 description 1
- 208000004062 Tumor Virus Infections Diseases 0.000 description 1
- 241001584775 Tunga penetrans Species 0.000 description 1
- 241000711508 Turkey coronavirus Species 0.000 description 1
- 241000385708 Turkeypox virus Species 0.000 description 1
- 241000008908 Tylonycteris bat coronavirus HKU4 Species 0.000 description 1
- 241001467018 Typhis Species 0.000 description 1
- 241000202921 Ureaplasma urealyticum Species 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 241000710959 Venezuelan equine encephalitis virus Species 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 241000061220 Werneckiella equi Species 0.000 description 1
- 241001492404 Woodchuck hepatitis virus Species 0.000 description 1
- 241000607734 Yersinia <bacteria> Species 0.000 description 1
- 241000607447 Yersinia enterocolitica Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 241000607477 Yersinia pseudotuberculosis Species 0.000 description 1
- 241001115400 Zaire ebolavirus Species 0.000 description 1
- 241000907316 Zika virus Species 0.000 description 1
- 241000606834 [Haemophilus] ducreyi Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000999 acridine dye Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 244000309743 astrovirus Species 0.000 description 1
- 201000008680 babesiosis Diseases 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 208000007456 balantidiasis Diseases 0.000 description 1
- 229940092524 bartonella henselae Drugs 0.000 description 1
- 239000003781 beta lactamase inhibitor Substances 0.000 description 1
- 229940126813 beta-lactamase inhibitor Drugs 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 229940011597 blastocystis hominis Drugs 0.000 description 1
- 229940074375 burkholderia mallei Drugs 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229940036735 ceftaroline Drugs 0.000 description 1
- ZCCUWMICIWSJIX-NQJJCJBVSA-N ceftaroline fosamil Chemical compound S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OCC)C=2N=C(NP(O)(O)=O)SN=2)CC=1SC(SC=1)=NC=1C1=CC=[N+](C)C=C1 ZCCUWMICIWSJIX-NQJJCJBVSA-N 0.000 description 1
- ORFOPKXBNMVMKC-DWVKKRMSSA-N ceftazidime Chemical compound S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC(C)(C)C(O)=O)C=2N=C(N)SC=2)CC=1C[N+]1=CC=CC=C1 ORFOPKXBNMVMKC-DWVKKRMSSA-N 0.000 description 1
- 229960000484 ceftazidime Drugs 0.000 description 1
- VAAUVRVFOQPIGI-SPQHTLEESA-N ceftriaxone Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NC(=O)C(=O)NN1C VAAUVRVFOQPIGI-SPQHTLEESA-N 0.000 description 1
- 229960004755 ceftriaxone Drugs 0.000 description 1
- 230000034303 cell budding Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 201000000902 chlamydia Diseases 0.000 description 1
- 208000012538 chlamydia trachomatis infectious disease Diseases 0.000 description 1
- 238000002487 chromatin immunoprecipitation Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000011928 denatured alcohol Substances 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 201000005889 eumycotic mycetoma Diseases 0.000 description 1
- 238000002270 exclusion chromatography Methods 0.000 description 1
- 108010052305 exodeoxyribonuclease III Proteins 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- YYJNOYZRYGDPNH-MFKUBSTISA-N fenpyroximate Chemical compound C=1C=C(C(=O)OC(C)(C)C)C=CC=1CO/N=C/C=1C(C)=NN(C)C=1OC1=CC=CC=C1 YYJNOYZRYGDPNH-MFKUBSTISA-N 0.000 description 1
- 101150064107 fosB gene Proteins 0.000 description 1
- 229940118764 francisella tularensis Drugs 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 229940085435 giardia lamblia Drugs 0.000 description 1
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
- 229960002182 imipenem Drugs 0.000 description 1
- ZSKVGTPCRGIANV-ZXFLCMHBSA-N imipenem Chemical compound C1C(SCC\N=C\N)=C(C(O)=O)N2C(=O)[C@H]([C@H](O)C)[C@H]21 ZSKVGTPCRGIANV-ZXFLCMHBSA-N 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940115932 legionella pneumophila Drugs 0.000 description 1
- 235000012902 lepidium meyenii Nutrition 0.000 description 1
- 229960003376 levofloxacin Drugs 0.000 description 1
- TYZROVQLWOKYKF-ZDUSSCGKSA-N linezolid Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C(C=C1F)=CC=C1N1CCOCC1 TYZROVQLWOKYKF-ZDUSSCGKSA-N 0.000 description 1
- 229960003907 linezolid Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 108010034959 macroH2A histone Proteins 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 101150021123 msrA gene Proteins 0.000 description 1
- 201000007524 mucormycosis Diseases 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000002487 multivesicular body Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 101150038610 penA gene Proteins 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229940118768 plasmodium malariae Drugs 0.000 description 1
- ZRZNJUXESFHSIO-VYTKZBNOSA-N pleuromutilin Chemical compound C([C@H]([C@]1(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]2C)OC(=O)CO)C)C[C@]32[C@H]1C(=O)CC3 ZRZNJUXESFHSIO-VYTKZBNOSA-N 0.000 description 1
- 201000000317 pneumocystosis Diseases 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- YAAWASYJIRZXSZ-UHFFFAOYSA-N pyrimidine-2,4-diamine Chemical compound NC1=CC=NC(N)=N1 YAAWASYJIRZXSZ-UHFFFAOYSA-N 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 229940046939 rickettsia prowazekii Drugs 0.000 description 1
- 229940075118 rickettsia rickettsii Drugs 0.000 description 1
- 229960003292 rifamycin Drugs 0.000 description 1
- HJYYPODYNSCCOU-ODRIEIDWSA-N rifamycin SV Chemical compound OC1=C(C(O)=C2C)C3=C(O)C=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O HJYYPODYNSCCOU-ODRIEIDWSA-N 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 229940116861 trichinella britovi Drugs 0.000 description 1
- 229940096911 trichinella spiralis Drugs 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 201000006266 variola major Diseases 0.000 description 1
- 201000000627 variola minor Diseases 0.000 description 1
- 208000014016 variola minor infection Diseases 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229940098232 yersinia enterocolitica Drugs 0.000 description 1
- 229940126085 β‑Lactamase Inhibitor Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6804—Nucleic acid analysis using immunogens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/10—Modifications characterised by
- C12Q2525/155—Modifications characterised by incorporating/generating a new priming site
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/10—Modifications characterised by
- C12Q2525/161—Modifications characterised by incorporating target specific and non-target specific sites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
- C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
- C12Q2537/159—Reduction of complexity, e.g. amplification of subsets, removing duplicated genomic regions
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562163273P | 2015-05-18 | 2015-05-18 | |
| US62/163,273 | 2015-05-18 | ||
| US201662334348P | 2016-05-10 | 2016-05-10 | |
| US62/334,348 | 2016-05-10 | ||
| PCT/US2016/032936 WO2016187234A1 (en) | 2015-05-18 | 2016-05-17 | Compositions and methods for enriching populations of nucleic acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2016264102A1 true AU2016264102A1 (en) | 2017-12-21 |
Family
ID=57320699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2016264102A Abandoned AU2016264102A1 (en) | 2015-05-18 | 2016-05-17 | Compositions and methods for enriching populations of nucleic acids |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US11111520B2 (https=) |
| EP (2) | EP3298169B1 (https=) |
| JP (3) | JP6873921B2 (https=) |
| CN (1) | CN107922971A (https=) |
| AU (1) | AU2016264102A1 (https=) |
| BR (1) | BR112017024747A2 (https=) |
| CA (1) | CA2986036C (https=) |
| IL (1) | IL255647B (https=) |
| WO (1) | WO2016187234A1 (https=) |
| ZA (1) | ZA201708264B (https=) |
Families Citing this family (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2971444A1 (en) | 2014-12-20 | 2016-06-23 | Arc Bio, Llc | Compositions and methods for targeted depletion, enrichment, and partitioning of nucleic acids using crispr/cas system proteins |
| CN107922971A (zh) | 2015-05-18 | 2018-04-17 | 凯锐思公司 | 用于富集核酸群体的组合物和方法 |
| AU2016308283B2 (en) | 2015-08-19 | 2022-04-21 | Arc Bio, Llc | Capture of nucleic acids using a nucleic acid-guided nuclease-based system |
| EP3377654B1 (en) | 2015-11-16 | 2024-01-31 | Revere Biosensors, LLC | Systems and methods for identifying and distinguishing genetic samples |
| CA3185611A1 (en) | 2016-03-25 | 2017-09-28 | Karius, Inc. | Synthetic nucleic acid spike-ins |
| GB2559319B (en) * | 2016-12-23 | 2019-01-16 | Cs Genetics Ltd | Reagents and methods for the analysis of linked nucleic acids |
| WO2018119399A1 (en) | 2016-12-23 | 2018-06-28 | Grail, Inc. | Methods for high efficiency library preparation using double-stranded adapters |
| WO2018140452A1 (en) | 2017-01-30 | 2018-08-02 | Counsyl, Inc. | Enrichment of cell-free dna from a biological sample |
| US11155805B2 (en) | 2017-03-27 | 2021-10-26 | Sekisui Medical Co., Ltd. | Target nucleic acid concentration and recovery method using antibody |
| US11274344B2 (en) | 2017-03-30 | 2022-03-15 | Grail, Inc. | Enhanced ligation in sequencing library preparation |
| WO2018183897A1 (en) * | 2017-03-31 | 2018-10-04 | Grail, Inc. | Higher target capture efficiency using probe extension |
| WO2018191563A1 (en) | 2017-04-12 | 2018-10-18 | Karius, Inc. | Sample preparation methods, systems and compositions |
| WO2018195951A1 (en) * | 2017-04-28 | 2018-11-01 | Coyote Diagnostics Lab (Beijing) Co., Ltd. | Integrated sample collection, processing and analysis systems |
| CN110869512A (zh) * | 2017-05-09 | 2020-03-06 | 雷瑞生物传感器有限责任公司 | 鉴别并区分遗传样品的系统及方法 |
| EP3697798A4 (en) * | 2017-10-18 | 2021-08-11 | Day Zero Diagnostics, Inc. | SELECTIVE ENRICHMENT OF A POPULATION OF DNA IN A MIXED DNA SAMPLE BY TARGETED DELETION OF DNA AMPLIFICATION |
| CN108220479B (zh) * | 2018-01-05 | 2021-08-13 | 浙江农林大学 | 能检测多种猪猝死症病原的多重连接探针扩增鉴别试剂盒 |
| CN110272984A (zh) * | 2018-03-13 | 2019-09-24 | 深圳华大生命科学研究院 | 测序获取寄生虫核酸信息及对寄生虫分类的方法和系统 |
| WO2019178188A1 (en) * | 2018-03-13 | 2019-09-19 | Microinvestigate, Llc | Direct-to-consumer genomic diagnostic device |
| WO2019178157A1 (en) | 2018-03-16 | 2019-09-19 | Karius, Inc. | Sample series to differentiate target nucleic acids from contaminant nucleic acids |
| AU2019239623B2 (en) | 2018-03-19 | 2022-03-10 | Illumina, Inc. | Methods and compositions for selective cleavage of nucleic acids with recombinant nucleases |
| GB201810571D0 (en) * | 2018-06-27 | 2018-08-15 | Cs Genetics Ltd | Reagents and methods for the analysis of circulating microparticles |
| CN112639983B (zh) | 2018-06-29 | 2024-06-04 | 豪夫迈·罗氏有限公司 | 微卫星不稳定性检测 |
| WO2020086967A1 (en) * | 2018-10-25 | 2020-04-30 | Quadrant Biosciences Inc. | Methods and machine learning for disease diagnosis |
| ES3059710T3 (en) | 2018-11-21 | 2026-03-23 | Karius Inc | Direct-to-library methods, systems, and compositions |
| CA3118742A1 (en) * | 2018-11-21 | 2020-05-28 | Karius, Inc. | Detection and prediction of infectious disease |
| JP7132100B2 (ja) * | 2018-11-21 | 2022-09-06 | 株式会社日立製作所 | 生体分子分析装置及び生体分子分析方法 |
| CN109355365A (zh) * | 2018-11-25 | 2019-02-19 | 中国农业科学院兰州兽医研究所 | 一种小rna高通量测序检测微生物的方法 |
| CN113039283B (zh) * | 2018-12-12 | 2023-12-26 | 深圳华大生命科学研究院 | 分离和/或富集宿主源核酸和病原核酸的方法和试剂及其制备方法 |
| SG11202104701XA (en) * | 2018-12-20 | 2021-06-29 | Guardant Health Inc | Methods, compositions, and systems for improving recovery of nucleic acid molecules |
| US12565676B2 (en) | 2019-03-01 | 2026-03-03 | Revere Biosensors, Llc | Systems and methods for separating decoded arrays |
| GB201902887D0 (en) * | 2019-03-04 | 2019-04-17 | St Georges Hospital Medical School | Detection and antibiotic resistance profiling of microorganisms |
| WO2020198664A1 (en) * | 2019-03-28 | 2020-10-01 | The Regents Of The University Of California | Methods and systems for sequencing cell-free microbiome dna |
| WO2020210356A1 (en) * | 2019-04-08 | 2020-10-15 | Zymo Research Corporation | Duplex-specific nuclease depletion for purification of nucleic acid samples |
| SG11202102801TA (en) * | 2019-04-29 | 2021-04-29 | Illumina Inc | Identification and analysis of microbial samples by rapid incubation and nucleic acid enrichment |
| US11396679B2 (en) | 2019-05-31 | 2022-07-26 | Universal Diagnostics, S.L. | Detection of colorectal cancer |
| EP4041888A4 (en) | 2019-10-11 | 2023-11-01 | Guardant Health, Inc. | USE OF CELLULAR BACTERIAL NUCLEIC ACIDS FOR CANCER DETECTION |
| US11898199B2 (en) | 2019-11-11 | 2024-02-13 | Universal Diagnostics, S.A. | Detection of colorectal cancer and/or advanced adenomas |
| EP4010489A1 (en) * | 2019-12-04 | 2022-06-15 | Illumina, Inc. | Preparation of dna sequencing libraries for detection of dna pathogens in plasma |
| WO2021122846A1 (en) * | 2019-12-16 | 2021-06-24 | Qiagen Gmbh | Enrichment method |
| CN111254190B (zh) * | 2020-01-20 | 2021-02-23 | 中国医学科学院病原生物学研究所 | 一种血浆病毒组学的纳米孔三代测序检测方法 |
| WO2021163692A1 (en) * | 2020-02-14 | 2021-08-19 | Rhode Island Hospital | Rna sequencing to diagnose sepsis |
| CN111239392B (zh) * | 2020-02-26 | 2023-04-21 | 浙江诺迦生物科技有限公司 | 一种新型冠状病毒肺炎(covid-19)血清学诊断试剂盒 |
| JP7522431B2 (ja) * | 2020-04-01 | 2024-07-25 | 国立大学法人北海道大学 | 動物試料からのウイルス検出方法 |
| CA3179579A1 (en) * | 2020-04-06 | 2021-10-14 | Octant, Inc. | Pathogen diagnostic test |
| WO2021228418A1 (en) | 2020-05-15 | 2021-11-18 | Universal Diagnostics, S.L. | Methods and systems for identifying methylation biomarkers |
| WO2022002424A1 (en) * | 2020-06-30 | 2022-01-06 | Universal Diagnostics, S.L. | Systems and methods for detection of multiple cancer types |
| CN117897504A (zh) * | 2021-02-12 | 2024-04-16 | 凯锐思公司 | 患有莱姆病的对象中的微生物无细胞核酸的宏基因组下一代测序 |
| US20220315986A1 (en) * | 2021-04-01 | 2022-10-06 | Diversity Arrays Technology Pty Limited | Processes for enriching desirable elements and uses therefor |
| CN113201599B (zh) * | 2021-06-03 | 2023-03-31 | 北京大学人民医院 | 一种基于PCR和nanopore测序检测脑脊液感染哪些病原体的方法 |
| CN113684249B (zh) * | 2021-08-25 | 2024-10-22 | 广州达安基因股份有限公司 | 一种rna和dna二代测序文库的构建方法及二代测序盒 |
| CN115786547A (zh) * | 2022-09-29 | 2023-03-14 | 武汉明德生物科技股份有限公司 | 用于病原微生物检测的引物组、试剂盒及其应用方法 |
| CN115786548A (zh) * | 2022-09-29 | 2023-03-14 | 武汉明德生物科技股份有限公司 | 用于病原微生物耐药基因检测的引物组、试剂盒及方法 |
| US12606872B2 (en) | 2022-11-16 | 2026-04-21 | Universal Diagnostics, S.A. | Methods for stratification and early detection of advanced adenoma and/or colorectal cancer using DNA methylation markers |
| AU2024246833A1 (en) | 2023-03-31 | 2025-09-25 | Toray Industries, Inc. | Pharmaceutical composition for treating and/or preventing cancer |
| AU2024257509A1 (en) * | 2023-04-18 | 2025-10-30 | Karius, Inc. | Sample processing to enrich for select species of nucleic acids |
| WO2025137492A1 (en) * | 2023-12-22 | 2025-06-26 | Siemens Healthcare Diagnostics Inc. | Method for enriching pathogen dna and implementation thereof |
| CN118165982A (zh) * | 2024-04-17 | 2024-06-11 | 上海麦克林生化科技股份有限公司 | Rna快速提取试剂盒及其应用 |
Family Cites Families (78)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9220773D0 (en) | 1992-10-02 | 1992-11-18 | Mini Agriculture & Fisheries | Detection of antigens and nucleic acids |
| US6759217B2 (en) | 1996-03-26 | 2004-07-06 | Oncomedx, Inc. | Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer |
| USRE39920E1 (en) | 1997-05-30 | 2007-11-13 | Xenomics, Inc. | Methods for detection of nucleic acid sequences in urine |
| US6753137B2 (en) | 2001-01-31 | 2004-06-22 | The Chinese University Of Hong Kong | Circulating epstein-barr virus DNA in the serum of patients with gastric carcinoma |
| US20050202414A1 (en) | 2001-11-15 | 2005-09-15 | The Regents Of The University Of California | Apparatus and methods for detecting a microbe in a sample |
| US7727720B2 (en) * | 2002-05-08 | 2010-06-01 | Ravgen, Inc. | Methods for detection of genetic disorders |
| US20040209299A1 (en) | 2003-03-07 | 2004-10-21 | Rubicon Genomics, Inc. | In vitro DNA immortalization and whole genome amplification using libraries generated from randomly fragmented DNA |
| US20060073506A1 (en) | 2004-09-17 | 2006-04-06 | Affymetrix, Inc. | Methods for identifying biological samples |
| ITRM20050067A1 (it) | 2005-02-17 | 2006-08-18 | Istituto Naz Per Le Malattie I | Metodo per la rivelazione di acidi nucleici virali o di origine virale nelle urine. |
| US7914982B2 (en) | 2005-02-17 | 2011-03-29 | Trovagene, Inc. | Methods for detecting pathogen specific nucleic acids in urine |
| AU2006214444B8 (en) | 2005-02-17 | 2012-04-05 | Trovagene, Inc. | Compositions and methods for detecting pathogen specific nucleic acids in urine |
| ITRM20050068A1 (it) | 2005-02-17 | 2006-08-18 | Istituto Naz Per Le Malattie I | Metodo per la rivelazione di acidi nucleici di agenti patogeni batterici o di parassiti nelle urine. |
| WO2006089203A2 (en) | 2005-02-17 | 2006-08-24 | Istituto Nazionale Per Le Malattie Infettive Irccs Lazzaro Spallanzani | Compositions and methods for detecting viral specific nucleic acids in urine |
| US20060292585A1 (en) * | 2005-06-24 | 2006-12-28 | Affymetrix, Inc. | Analysis of methylation using nucleic acid arrays |
| US8532930B2 (en) | 2005-11-26 | 2013-09-10 | Natera, Inc. | Method for determining the number of copies of a chromosome in the genome of a target individual using genetic data from genetically related individuals |
| EP3260556B1 (en) | 2006-05-31 | 2019-07-31 | Sequenom, Inc. | Methods for the extraction of nucleic acid from a sample |
| CN105400868B (zh) | 2007-08-22 | 2021-03-26 | 特罗瓦基因公司 | 使用miRNA检测体内细胞死亡情况的方法 |
| WO2009032781A2 (en) * | 2007-08-29 | 2009-03-12 | Sequenom, Inc. | Methods and compositions for universal size-specific polymerase chain reaction |
| DE102007041864B4 (de) | 2007-09-04 | 2012-05-03 | Sirs-Lab Gmbh | Verfahren zum Nachweis von Bakterien und Pilzen |
| WO2009036525A2 (en) | 2007-09-21 | 2009-03-26 | Katholieke Universiteit Leuven | Tools and methods for genetic tests using next generation sequencing |
| WO2009102470A2 (en) | 2008-02-12 | 2009-08-20 | Pacific Biosciences Of California, Inc. | Compositions and methods for use in analytical reactions |
| ES2595489T3 (es) * | 2008-07-18 | 2016-12-30 | Trovagene, Inc. | Métodos para la detección de secuencias de ácidos nucleicos "ultracortos" basados en PCR |
| US20120190663A1 (en) | 2009-08-06 | 2012-07-26 | Cedars-Sinai Medical Center | Use of free dna as an early predictor of severity in acute pancreatitis |
| LT3783110T (lt) * | 2009-11-05 | 2023-01-25 | The Chinese University Of Hong Kong | Vaisiaus genomo analizė iš motinos biologinio mėginio |
| HUE052213T2 (hu) | 2009-11-06 | 2021-04-28 | Univ Leland Stanford Junior | Grafitkilökõdés nem invazív diagnosztizálása szervátültetett betegekben |
| WO2011100617A2 (en) | 2010-02-12 | 2011-08-18 | Life Technologies Corporation | Nucleic acid, biomolecule and polymer identifier codes |
| WO2011143659A2 (en) | 2010-05-14 | 2011-11-17 | Fluidigm Corporation | Nucleic acid isolation methods |
| US20120077185A1 (en) | 2010-08-06 | 2012-03-29 | Tandem Diagnostics, Inc. | Detection of genetic abnormalities and infectious disease |
| EP2426217A1 (en) | 2010-09-03 | 2012-03-07 | Centre National de la Recherche Scientifique (CNRS) | Analytical methods for cell free nucleic acids and applications |
| WO2012044956A1 (en) * | 2010-10-01 | 2012-04-05 | Ibis Biosciences, Inc. | Targeted genome amplification methods |
| CA2822439A1 (en) | 2010-12-23 | 2012-06-28 | Sequenom, Inc. | Fetal genetic variation detection |
| AU2012236109A1 (en) | 2011-04-01 | 2013-11-21 | Occam Biolabs, Inc. | Methods and kits for detecting cell-free pathogen-specific nucleic acids |
| US20140179726A1 (en) | 2011-05-19 | 2014-06-26 | Virginia Commonwealth University | Gut microflora as biomarkers for the prognosis of cirrhosis and brain dysfunction |
| EP2718862B1 (en) | 2011-06-06 | 2018-10-31 | Koninklijke Philips N.V. | Method for assembly of nucleic acid sequence data |
| US20130024127A1 (en) | 2011-07-19 | 2013-01-24 | John Stuelpnagel | Determination of source contributions using binomial probability calculations |
| GB201115095D0 (en) | 2011-09-01 | 2011-10-19 | Singapore Volition Pte Ltd | Method for detecting nucleosomes containing nucleotides |
| EP2758538B1 (en) | 2011-09-22 | 2018-10-31 | Lineage Biosciences, Inc. | Methods for analyzing heterogeneous samples |
| CA2850785C (en) | 2011-10-06 | 2022-12-13 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| WO2013109981A1 (en) | 2012-01-20 | 2013-07-25 | Sequenom, Inc. | Diagnostic processes that factor experimental conditions |
| WO2013113012A2 (en) | 2012-01-27 | 2013-08-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for profiling and quantitating cell-free rna |
| HK1206055A1 (en) * | 2012-03-02 | 2015-12-31 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| WO2013134261A1 (en) * | 2012-03-05 | 2013-09-12 | President And Fellows Of Harvard College | Systems and methods for epigenetic sequencing |
| US9892230B2 (en) | 2012-03-08 | 2018-02-13 | The Chinese University Of Hong Kong | Size-based analysis of fetal or tumor DNA fraction in plasma |
| JP6411995B2 (ja) | 2012-03-13 | 2018-10-24 | ザ チャイニーズ ユニバーシティー オブ ホンコン | 非侵襲的出生前診断のために大量並列シークエンシング・データを分析する方法 |
| AU2013249012B2 (en) | 2012-04-19 | 2019-03-28 | The Medical College Of Wisconsin, Inc. | Highly sensitive surveillance using detection of cell free DNA |
| EP2653562A1 (en) | 2012-04-20 | 2013-10-23 | Institut Pasteur | Anellovirus genome quantification as a biomarker of immune suppression |
| EP4026912A1 (en) * | 2012-05-10 | 2022-07-13 | The General Hospital Corporation | Methods for determining a nucleotide sequence |
| US10504613B2 (en) | 2012-12-20 | 2019-12-10 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US9920361B2 (en) | 2012-05-21 | 2018-03-20 | Sequenom, Inc. | Methods and compositions for analyzing nucleic acid |
| WO2013188846A1 (en) | 2012-06-15 | 2013-12-19 | Harry Stylli | Methods of detecting diseases or conditions |
| WO2014019275A1 (en) | 2012-07-31 | 2014-02-06 | Bgi Shenzhen Co., Limited | Noninvasive detection of fetal health status |
| US10233508B2 (en) | 2012-08-21 | 2019-03-19 | Qiagen Gmbh | Virus particle stabilisation and method for isolating viral nucleic acids |
| US9316802B2 (en) | 2012-08-24 | 2016-04-19 | Commscope Technologies Llc | Optical fiber cable having reinforcing layer of tape heat-bonded to jacket |
| GB2533006B (en) | 2012-09-04 | 2017-06-07 | Guardant Health Inc | Systems and methods to detect copy number variation |
| US20140066317A1 (en) | 2012-09-04 | 2014-03-06 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| EP2728014B1 (en) | 2012-10-31 | 2015-10-07 | Genesupport SA | Non-invasive method for detecting a fetal chromosomal aneuploidy |
| GB201302900D0 (en) | 2013-02-19 | 2013-04-03 | Genome Res Ltd | Nucleic acid marker molecules for identifying and detecting cross contaminationof nucleic acid samples |
| US20140242582A1 (en) | 2013-02-28 | 2014-08-28 | Ariosa Diagnostics, Inc. | Detection of genetic abnormalities using ligation-based detection and digital pcr |
| CN113337604A (zh) | 2013-03-15 | 2021-09-03 | 莱兰斯坦福初级大学评议会 | 循环核酸肿瘤标志物的鉴别和用途 |
| GB2528205B (en) | 2013-03-15 | 2020-06-03 | Guardant Health Inc | Systems and methods to detect rare mutations and copy number variation |
| US10017807B2 (en) | 2013-03-15 | 2018-07-10 | Verinata Health, Inc. | Generating cell-free DNA libraries directly from blood |
| US9578045B2 (en) | 2013-05-03 | 2017-02-21 | Webroot Inc. | Method and apparatus for providing forensic visibility into systems and networks |
| US9499870B2 (en) * | 2013-09-27 | 2016-11-22 | Natera, Inc. | Cell free DNA diagnostic testing standards |
| US20150119260A1 (en) | 2013-10-18 | 2015-04-30 | National Taiwan University | Circulating cancer biomarker and its use |
| JP7451070B2 (ja) | 2013-11-07 | 2024-03-18 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | ヒトミクロビオームおよびその成分の分析のための無細胞核酸 |
| WO2015085105A1 (en) | 2013-12-04 | 2015-06-11 | University Of Alaska Fairbanks | Methods and compositions for enriching non-host sequences in host samples |
| CN107922971A (zh) | 2015-05-18 | 2018-04-17 | 凯锐思公司 | 用于富集核酸群体的组合物和方法 |
| CA3185611A1 (en) | 2016-03-25 | 2017-09-28 | Karius, Inc. | Synthetic nucleic acid spike-ins |
| BR112019002679A2 (pt) | 2016-08-08 | 2019-05-14 | Karius, Inc. | redução de sinal de ácidos nucleicos contaminantes |
| WO2018045359A1 (en) | 2016-09-02 | 2018-03-08 | Karius, Inc. | Detection and treatment of infection during pregnancy |
| WO2018191563A1 (en) | 2017-04-12 | 2018-10-18 | Karius, Inc. | Sample preparation methods, systems and compositions |
| WO2019178157A1 (en) | 2018-03-16 | 2019-09-19 | Karius, Inc. | Sample series to differentiate target nucleic acids from contaminant nucleic acids |
| CA3118742A1 (en) | 2018-11-21 | 2020-05-28 | Karius, Inc. | Detection and prediction of infectious disease |
| ES3059710T3 (en) | 2018-11-21 | 2026-03-23 | Karius Inc | Direct-to-library methods, systems, and compositions |
| US20220195496A1 (en) | 2020-12-17 | 2022-06-23 | Karius, Inc. | Sequencing microbial cell-free dna from asymptomatic individuals |
| EP4263866A4 (en) | 2020-12-21 | 2024-12-04 | Karius, Inc. | Sequencing microbial cell-free nucleic acids to detect inflammation, secondary infection, and disease severity |
| EP4274913A4 (en) | 2021-01-11 | 2024-12-11 | Karius Inc. | RAPID NON-INVASIVE DETECTION AND SERIAL MONITORING OF INFECTIONS IN SUBJECTS USING MICROBIAL CELL-FREE DNA SEQUENCING |
| CN117897504A (zh) | 2021-02-12 | 2024-04-16 | 凯锐思公司 | 患有莱姆病的对象中的微生物无细胞核酸的宏基因组下一代测序 |
-
2016
- 2016-05-17 CN CN201680042387.4A patent/CN107922971A/zh active Pending
- 2016-05-17 WO PCT/US2016/032936 patent/WO2016187234A1/en not_active Ceased
- 2016-05-17 US US15/157,374 patent/US11111520B2/en active Active
- 2016-05-17 AU AU2016264102A patent/AU2016264102A1/en not_active Abandoned
- 2016-05-17 JP JP2017560813A patent/JP6873921B2/ja active Active
- 2016-05-17 EP EP16797172.0A patent/EP3298169B1/en active Active
- 2016-05-17 EP EP24194575.7A patent/EP4450636A3/en active Pending
- 2016-05-17 CA CA2986036A patent/CA2986036C/en active Active
- 2016-05-17 BR BR112017024747A patent/BR112017024747A2/pt not_active IP Right Cessation
-
2017
- 2017-11-14 IL IL255647A patent/IL255647B/en unknown
- 2017-12-05 ZA ZA2017/08264A patent/ZA201708264B/en unknown
-
2021
- 2021-04-21 JP JP2021071794A patent/JP7769480B2/ja active Active
- 2021-07-30 US US17/390,550 patent/US12291739B2/en active Active
-
2023
- 2023-05-31 JP JP2023090282A patent/JP2023110928A/ja active Pending
-
2025
- 2025-01-17 US US19/030,917 patent/US20260002197A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2021112200A (ja) | 2021-08-05 |
| IL255647B (en) | 2022-04-01 |
| US20260002197A1 (en) | 2026-01-01 |
| JP2023110928A (ja) | 2023-08-09 |
| EP3298169A4 (en) | 2018-10-24 |
| EP3298169B1 (en) | 2024-10-02 |
| US12291739B2 (en) | 2025-05-06 |
| US11111520B2 (en) | 2021-09-07 |
| CN107922971A (zh) | 2018-04-17 |
| BR112017024747A2 (pt) | 2018-11-13 |
| JP2018520652A (ja) | 2018-08-02 |
| EP3298169A1 (en) | 2018-03-28 |
| US20220154246A1 (en) | 2022-05-19 |
| ZA201708264B (en) | 2022-03-30 |
| IL255647A (en) | 2018-01-31 |
| EP4450636A3 (en) | 2025-01-01 |
| US20170016048A1 (en) | 2017-01-19 |
| JP7769480B2 (ja) | 2025-11-13 |
| HK1251946A1 (en) | 2019-05-03 |
| EP4450636A2 (en) | 2024-10-23 |
| CA2986036A1 (en) | 2016-11-24 |
| WO2016187234A1 (en) | 2016-11-24 |
| CA2986036C (en) | 2022-07-26 |
| JP6873921B2 (ja) | 2021-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12291739B2 (en) | Compositions and methods for enriching populations of nucleic acids | |
| US20240344111A1 (en) | Sample series to differentiate target nucleic acids from contaminant nucleic acids | |
| JP7300831B2 (ja) | ゲノムアセンブリ、ハプロタイプフェージング、および標的に依存しない核酸検出のための方法 | |
| CA3014070C (en) | Synthetic nucleic acid spike-ins | |
| JP2022095676A (ja) | 保存されたサンプルからの長距離連鎖情報の回復 | |
| EP2539467A2 (en) | Methods of diagnosing infectious disease pathogens and their drug sensitivity | |
| HK40116790A (en) | Compositions and methods for enriching populations of nucleic acids | |
| HK1251946B (en) | Compositions and methods for enriching populations of nucleic acids | |
| US20250305029A1 (en) | Generation of phased read-sets for genome assembly and haplotype phasing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |